Onyx (ONXX) Shares Falling as FDA Grants Standard Review to NDA for Carfilzomib
Go back to Onyx (ONXX) Shares Falling as FDA Grants Standard Review to NDA for Carfilzomib| Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) | Delayed: 124.70 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $124.70 | 52 Week High | $136.87 | |||
| Open | $124.70 | 52 Week Low | $68.12 | |||
| Day High | $124.70 | P/E | N/A | |||
| Day Low | $124.70 | EPS | $-1.58 | |||
| Volume | 514,854 | |||||
